These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2040801)

  • 1. Polymorphic HLA-DR7 beta 1 chain residues that are involved in T cell allorecognition.
    Rosen-Bronson S; Yu WY; Karr RW
    J Immunol; 1991 Jun; 146(12):4264-70. PubMed ID: 2040801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-specific T cells with monogamous or promiscuous restriction patterns are sensitive to different HLA-DR beta chain substitutions.
    Karr RW; Panina-Bordignon P; Yu WY; Lanzavecchia A
    J Immunol; 1991 Jun; 146(12):4242-7. PubMed ID: 2040799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition.
    Coppin HL; Carmichael P; Lombardi G; L'Faqihi FE; Salter R; Parham P; Lechler RI; de Preval C
    Eur J Immunol; 1993 Feb; 23(2):343-9. PubMed ID: 8436170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonrandom selection of T cell specificities in anti-HLA-DR responses. Sequence motifs of the responder HLA-DR allele influence T cell recruitment.
    Weyand CM; Hicok KC; Goronzy JJ
    J Immunol; 1991 Jul; 147(1):70-8. PubMed ID: 2051028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of amino acid substitutions in the beta-sheet floor and alpha-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes.
    Mattson DH; Shimojo N; Cowan EP; Baskin JJ; Turner RV; Shvetsky BD; Coligan JE; Maloy WL; Biddison WE
    J Immunol; 1989 Aug; 143(4):1101-7. PubMed ID: 2473117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the third, but not the first or second, hypervariable regions of DR(beta 1*0101) eliminate DR1-restricted recognition of a pertussis toxin peptide.
    Olson RR; De Magistris MT; Di Tommaso A; Karr RW
    J Immunol; 1992 May; 148(9):2703-8. PubMed ID: 1573265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
    Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
    J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell receptor and peptide-contacting residues in the HLA-DR17(3) beta 1 chain.
    Geluk A; Fu XT; van Meijgaarden KE; Jansen YY; De Vries RR; Karr RW; Ottenhoff TH
    Eur J Immunol; 1994 Dec; 24(12):3241-4. PubMed ID: 7805754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition.
    Krieger JI; Karr RW; Grey HM; Yu WY; O'Sullivan D; Batovsky L; Zheng ZL; Colón SM; Gaeta FC; Sidney J
    J Immunol; 1991 Apr; 146(7):2331-40. PubMed ID: 1706393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic residues on the I-A beta chain modulate the stimulation of T cell clones specific for the N-terminal peptide of the autoantigen myelin basic protein.
    Davis CB; Mitchell DJ; Wraith DC; Todd JA; Zamvil SS; McDevitt HO; Steinman L; Jones PP
    J Immunol; 1989 Oct; 143(7):2083-93. PubMed ID: 2476496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloreactive T cells can distinguish between the same human class II MHC products on different B cell lines.
    Santamaria P; Boyce-Jacino MT; Lindstrom AL; Rich SS; Faras AJ; Barbosa JJ
    J Immunol; 1991 Mar; 146(6):1822-8. PubMed ID: 1706381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of polymorphic HLA-DR beta chain residues in presentation of viral antigens to T cells.
    Karr RW; Yu W; Watts R; Evans KS; Celis E
    J Exp Med; 1990 Jul; 172(1):273-83. PubMed ID: 2358778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual effects of the DR11-variable beta-chain residues 67, 71, and 86 upon DR(alpha,beta 1*1101)-restricted, peptide-specific T cell proliferation.
    McKinney JS; Fu XT; Swearingen C; Klohe E; Karr RW
    J Immunol; 1994 Dec; 153(12):5564-71. PubMed ID: 7989758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of peptide residues interacting with MHC molecule or T cell receptor. Can a peptide bind in more than one way to the same MHC molecule?
    Kurata A; Berzofsky JA
    J Immunol; 1990 Jun; 144(12):4526-35. PubMed ID: 2141038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple regions of HLA-DR beta 1 chains determine polymorphic epitopes recognized by monoclonal antibodies.
    Alber CA; Watts R; Klohe EP; Drover S; Marshall WH; Radka SF; Karr RW
    J Immunol; 1989 Oct; 143(7):2248-55. PubMed ID: 2476501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional sites on the A alpha-chain. Polymorphic residues involved in antigen presentation to insulin-specific, Ab alpha:Ak beta-restricted T cells.
    Reske-Kunz AB; Landais D; Peccoud J; Benoist C; Mathis D
    J Immunol; 1989 Sep; 143(5):1472-81. PubMed ID: 2474599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition.
    Boehncke WH; Takeshita T; Pendleton CD; Houghten RA; Sadegh-Nasseri S; Racioppi L; Berzofsky JA; Germain RN
    J Immunol; 1993 Jan; 150(2):331-41. PubMed ID: 8093457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between the amino-terminal domains of MHC class II molecules have a profound effect on serologic and T cell recognition: an analysis using recombinant HLA-DR/H-2E molecules.
    Barber LD; Lechler RI
    J Immunol; 1991 Oct; 147(7):2346-53. PubMed ID: 1717556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of DR4Dw4 beta chain residues 70, 71, and 86 in peptide binding and T cell recognition.
    Signorelli KL; Watts LM; Lambert LE
    Cell Immunol; 1995 May; 162(2):217-24. PubMed ID: 7743549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.